Compliance & Medical Disclaimer
This article is for informational and educational purposes only and does not constitute medical, legal, regulatory, or professional advice. The compounds discussed are research chemicals not approved for human consumption by the US FDA, European Medicines Agency (EMA), UK MHRA, Australian TGA, Health Canada, or any other major regulatory authority. They are sold strictly for laboratory research use. WolveStack does not employ medical staff, does not diagnose, treat, or prescribe, and makes no health claims under FTC, UK ASA, EU MDR/UCPD, or AU TGA standards. Always consult a licensed healthcare professional in your jurisdiction before considering any peptide protocol. This site contains affiliate links (FTC 2023 endorsement guidelines compliant); we may earn a commission on qualifying purchases at no additional cost to you. Some compounds discussed are on the WADA prohibited list — competitive athletes should verify current status with their governing body before any research use. Use of research chemicals may be illegal in your jurisdiction.
IMPORTANT: This compound is currently on the World Anti-Doping Agency (WADA) prohibited list. Competitive athletes face sanctions for use including in retirement testing programs. Verify current WADA status with your sport's governing body before any research involvement.
Editorial policy
Editorial review process: WolveStack Research Team — collective expertise in peptide pharmacology, regulatory science, and research literature analysis. We synthesize peer-reviewed studies, regulatory filings, and clinical trial data; we do not provide medical advice or treatment recommendations. Content is reviewed and updated as new evidence emerges.
Medical Disclaimer
For informational and educational purposes only. Not FDA-approved for human use. Consult a licensed healthcare professional. See full disclaimer.
GHRP-6 commonly causes intense appetite stimulation, elevated cortisol, prolactin elevation, water retention (2-5 lbs), sleep disruption at high doses, and potential injection site reactions. Most side effects are dose-dependent and resolve 4-8 weeks after discontinuing. Appetite stimulation is the most challenging side effect for many users.
Appetite Stimulation
Most common and challenging side effect. GHRP-6 activates hypothalamic ghrelin pathways, producing intense hunger described as 'agonizing' by users. Magnitude varies 5-50 fold between individuals. Low doses (100-150 mcg) produce manageable hunger; high doses (300 mcg) produce overwhelming appetite. Appetite habituates slightly over 2-3 weeks but never fully disappears. Management: strategic injection timing around meals, increased training volume to stimulate appetite, careful calorie tracking.
Cortisol Elevation
GHRP-6 activates hypothalamic CRH neurons, increasing ACTH-mediated adrenal cortisol secretion. Low doses (100-150 mcg) produce modest elevation (10-20% above baseline); high doses (300 mcg) produce substantial elevation (50-100% above baseline). Peak cortisol elevation occurs 30-60 minutes post-injection, returning toward baseline by 120-180 minutes. Transient elevation doesn't produce chronic cortisol dysregulation characteristic of chronic stress. Doses above 200 mcg administered three times daily may produce cumulative cortisol effects.
Prolactin Elevation
GHRP-6 increases prolactin through dopamine antagonism in hypothalamic tissue. Peak elevation 30-60 minutes post-injection. Doses 100-200 mcg produce modest elevation to upper-normal range (15-25 ng/mL). Most users experience asymptomatic elevation without clinical significance. Pain-sensitive users may experience mild breast tenderness, reduced libido, or mood changes. Prolactin elevation completely normalizes 4-8 weeks post-cycle.
Water Retention
GH promotes sodium reabsorption in renal collecting ducts, leading to mild fluid retention. Typical 8-week cycles produce 2-5 lbs intramuscular water retention. This is intramuscular (within muscle cells) rather than subcutaneous, providing joint lubrication benefits. Water retention dissipates within 2-4 weeks of discontinuing GHRP-6. Users with hypertension or edema-prone conditions should monitor fluid status.
Sleep Disruption
High doses (300+ mcg) three times daily may disrupt sleep quality, particularly with evening injections. Sleep disruption appears dose and timing-dependent. Evening injections 3-4 hours before bedtime typically avoid sleep interference. Sleep quality often improves after GH axis normalizes post-cycle.
Injection Site Reactions
Mild post-injection redness, bruising, or tender nodules resolve within 24-48 hours (normal inflammatory response). Lipohypertrophy (fatty lumps) develops with repeated injections at identical sites—prevent through strict site rotation. Lipoatrophy (fat loss) similarly prevented by rotation. Infection signs (redness, warmth, pus, fever) require immediate medical attention and antibiotics.
Receptor Desensitization
Continuous use reduces GH response magnitude over 3-4 weeks. This isn't strictly a 'side effect' but rather reduced efficacy. Prevention requires cycling: 8-12 weeks on, 4-8 weeks off for complete resensitization.
Trusted Research-Grade Sources
Below are the two vendors we recommend for research peptides — both publish independent third-party Certificates of Analysis (COAs) and ship internationally. Affiliate links: we earn a small commission at no extra cost to you (see Affiliate Disclosure).
Particle Peptides
Independently HPLC-tested, transparent COAs, comprehensive product range.
Browse Particle Peptides →Limitless Life Nootropics
Premium research peptides with strong customer support and verified purity.
Browse Limitless Life →FAQ: Side Effects
Will side effects go away?
Yes. All side effects are transient and resolve completely 4-8 weeks after discontinuing GHRP-6. Appetite stimulation, cortisol elevation, prolactin elevation, and water retention all normalize with discontinuation.
Can I manage appetite stimulation?
Partially. Strategic injection timing around meals, increased training frequency to stimulate appetite through workout, and careful calorie tracking help manage appetite. However, fundamental hunger drive cannot be completely suppressed. Some users reduce doses to tolerable level.
Does cortisol elevation cause harm?
Transient 30-60 minute elevation (even if substantial) doesn't produce chronic cortisol dysregulation or muscle catabolic effects seen with prolonged stress. The brief elevation appears benign in context of positive anabolic effects from GH/IGF-1 elevation.
Will water retention make me look bloated?
Typically not. Water retention is primarily intramuscular (within muscle cells) rather than subcutaneous (under skin). Most users appear fuller/more pumped rather than bloated. Dissipates within 2-4 weeks post-cycle.